Please use this identifier to cite or link to this item:
|Title:||Novel alternatives to reduce powder retention in the dry powder inhaler during aerosolization|
Dry powder inhaler
Force control agents
|Source:||Heng, D., Lee, S.H., Ng, W.K., Chan, H.-K., Kwek, J.W., Tan, R.B.H. (2013). Novel alternatives to reduce powder retention in the dry powder inhaler during aerosolization. International Journal of Pharmaceutics 452 (1-2) : 194-200. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijpharm.2013.05.006|
|Abstract:||Dry powder inhalers (DPIs) are used predominantly for the treatment of pulmonary diseases by delivering drugs directly into the lungs. The drug delivery efficiency is typically low and there is significant drug retention inside the DPI. An innovative 'green' initiative aimed at minimizing drug wastage via channeling the residual drug into the useful inhaled therapeutic fraction was pioneered. Drug retention could be minimized via coating the drug capsule and delivery device with pharmaceutically acceptable forcecontrol agents. This coating reduces the adhesion between the drug particles and the internal surfaces of the DPI, which in turn increases the fine particle dose by as much as 300%. © 2013 Elsevier B.V. All rights reserved.|
|Source Title:||International Journal of Pharmaceutics|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 16, 2018
WEB OF SCIENCETM
checked on Nov 22, 2017
checked on Jan 20, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.